Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06917456Completed

Novel VR Intervention for Use in Psychiatric Inpatient Wards

Role: lead

NCT07228650Recruiting

ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes

Role: collaborator

NCT05455450Not ApplicableCompleted

Eye MOvement DesensItisation and Reprocessing Therapy (EMDR) for FunctIonal Neurological Disorder (FND)

Role: lead

NCT05301673Active Not Recruiting

ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence

Role: collaborator

NCT03563755Not ApplicableUnknown

Social Information Processing in Adolescents With Eating Disorders

Role: collaborator

All 5 trials loaded